Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 9.30
-0.60 (-6.06%)
Sep 24, 2026, 5:23 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 65.65 million as of September 24, 2026. Its market cap has decreased by -68.37% in one year.
Market Cap
65.65M
Enterprise Value
60.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.30
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 65.65M, an increase of 30.75%. That is a compound annual growth rate of 2.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 65.65M | -53.03% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 107.95M |
| Nanologica AB | 100.60M |
| Biovica International AB | 92.24M |
| Ascelia Pharma AB | 82.79M |
| Alzinova AB | 81.46M |
| Pila Pharma AB | 79.26M |
| Spago Nanomedical AB | 78.08M |
| AcouSort AB | 63.70M |